サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1643372

バルーン弁形成術装置の世界市場

Balloon Valvuloplasty Devices

出版日
ページ情報
英文 277 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
バルーン弁形成術装置の世界市場
出版日: 2025年01月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 277 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

バルーン弁形成術装置の世界市場は2030年までに27億米ドルに達する

2024年に23億米ドルと推定されるバルーン弁形成術装置の世界市場は、2024～2030年の分析期間においてCAGR 2.8%で成長し、2030年には27億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである大動脈弁狭窄症アプリケーションは、CAGR 2.4%を記録し、分析期間終了までに17億米ドルに達すると予測されます。肺動脈弁狭窄症アプリケーションセグメントの成長率は、分析期間中CAGR 3.4%と推定されます。

米国市場は6億2,370万米ドルと推定、中国はCAGR5.2％で成長予測

米国のバルーン弁形成術装置市場は、2024年に6億2,370万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを5.2%として、2030年までに5億2,200万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.1%と2.1%と予測されています。欧州では、ドイツがCAGR 1.5%で成長すると予測されています。

世界のバルーン弁形成術装置市場- 主要動向と促進要因まとめ

低侵襲手術の進歩はどのように普及を促進しているか？

低侵襲治療への嗜好の高まりが、バルーン弁形成術装置の需要を大きく促進しています。これらのデバイスは、大動脈弁狭窄症や僧帽弁狭窄症などの心臓弁膜症の治療に広く使用されており、開心術に代わる低侵襲性を提供しています。バルーン弁形成術の低侵襲性は、回復時間の短縮、合併症リスクの低減、患者の転帰の改善につながり、ヘルスケアプロバイダーや患者の間で好ましい選択肢となっています。

バルーン弁形成術装置では、カテーテル設計の改良、画像ガイダンスの強化、正確なバルーンサイジングなどの技術革新が、バルーン弁形成術の採用にさらに貢献しています。これらの進歩により、心臓専門医は複雑な症例であっても高精度で効果的な手技を行うことができます。その結果、心血管疾患の有病率の増加や高度な治療オプションの必要性に後押しされ、これらの機器に対する需要は上昇基調を続けると予想されます。

なぜ心臓弁膜症の有病率の上昇が市場促進要因なのか？

心臓弁膜症の有病率の上昇、特に高齢化人口の増加が、バルーン弁形成術装置市場の成長を促進する重要な要因です。大動脈弁狭窄症や僧帽弁閉鎖不全症などの疾患は、世界の平均寿命の向上とともにますます一般的になってきています。これらの疾患は、心不全、脳卒中、突然の心停止などの合併症を防ぐために、しばしばタイムリーな医療介入が必要となります。

バルーン弁形成術は、特に外科的弁置換術の適応とならない高リスクの患者にとって、貴重な治療オプションです。このため、世界中のヘルスケア施設がバルーン弁形成術を導入し、効果的な治療を受けられるようになりました。さらに、弁膜症の早期診断と治療に対する意識の高まりは、より多くの患者が医療機関を受診することを促し、バルーン弁形成術装置市場を後押ししています。

技術の進歩はどのように機器の効率を向上させているのか？

バルーン弁形成術装置の技術的進歩により、効率性と安全性が大幅に向上しています。各メーカーは、高圧バルーン、高度な操縦性、画像システムとの互換性向上などの特徴を備えた次世代デバイスの開発に注力しています。これらの改良により、正確な留置と拡張が可能になり、周辺組織への損傷リスクを最小限に抑えることができます。

さらに、リアルタイム画像やナビゲーションシステムなどのデジタルツールの統合は、手技の精度に革命をもたらしています。これらのツールは、臨床医が手技中に器具を視覚化し、ガイドすることを可能にし、最適な結果を保証します。さらに、生体適合性ポリマーや柔軟なデザインなどの素材の革新は、患者の快適性を向上させ、処置後の合併症の可能性を減らしています。こうした技術的進歩は、バルーン弁形成術の有効性を高めるだけでなく、より幅広い患者層への適用を拡大しています。

バルーン弁形成術装置市場の成長を促す要因とは？

バルーン弁形成術装置市場の成長は、心臓弁膜症の有病率の増加、低侵襲技術の進歩、デバイス効率の継続的改善など、いくつかの要因によって牽引されています。世界の高齢化とそれに伴う心血管系疾患の増加により、効果的な治療オプションに対する緊急のニーズが高まっており、バルーン弁形成術は重要な治療法となっています。

消費者行動、特に回復時間の短い低侵襲手術に対する需要の高まりが、市場力学を形成しています。高度な画像ガイダンスやカテーテル設計の改良といった技術革新は、手技の成果を高めることで市場の拡大をさらに後押ししています。さらに、ヘルスケアインフラへの投資の増加や、弁膜症への早期介入の利点に対する意識の高まりが、普及を後押ししています。これらの要因が、世界のバルーン弁形成術装置市場の堅調な成長軌道を裏付けています。

セグメント

用途（大動脈弁狭窄症用途、肺動脈弁狭窄症用途）;最終用途（病院最終用途、外来手術センター最終用途、心臓カテーテル検査室最終用途）

調査対象企業の例（注目の43社）

  • B. Braun Interventional Systems, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • BrosMed Medical Company Limited
  • Edwards Lifesciences Corporation
  • Getinge AB（Getinge Group）
  • Koninklijke Philips NV
  • Medtronic Plc
  • Stryker Corporation
  • Terumo Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP29463

Global Balloon Valvuloplasty Devices Market to Reach US$2.7 Billion by 2030

The global market for Balloon Valvuloplasty Devices estimated at US$2.3 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Aortic Valve Stenosis Application, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Pulmonary Valve Stenosis Application segment is estimated at 3.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$623.7 Million While China is Forecast to Grow at 5.2% CAGR

The Balloon Valvuloplasty Devices market in the U.S. is estimated at US$623.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$522.0 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Balloon Valvuloplasty Devices Market - Key Trends & Drivers Summarized

How Are Advancements in Minimally Invasive Procedures Driving Adoption?

The growing preference for minimally invasive procedures is significantly propelling the demand for balloon valvuloplasty devices. These devices are widely used in the treatment of valvular heart diseases, such as aortic stenosis and mitral stenosis, offering a less invasive alternative to open-heart surgery. The minimally invasive nature of balloon valvuloplasty results in reduced recovery times, lower risk of complications, and improved patient outcomes, making it a preferred choice among healthcare providers and patients.

Technological innovations in balloon valvuloplasty devices, such as improved catheter designs, enhanced imaging guidance, and precise balloon sizing, are further contributing to their adoption. These advancements enable cardiologists to perform highly accurate and effective procedures, even in complex cases. As a result, the demand for these devices is expected to continue its upward trajectory, driven by the increasing prevalence of cardiovascular diseases and the need for advanced treatment options.

Why Is the Rising Prevalence of Valvular Heart Diseases a Key Market Driver?

The rising prevalence of valvular heart diseases, particularly among the aging population, is a critical factor driving the growth of the balloon valvuloplasty devices market. Conditions such as aortic stenosis and mitral regurgitation are becoming increasingly common as global life expectancy improves. These diseases often require timely medical intervention to prevent complications such as heart failure, stroke, or sudden cardiac arrest.

Balloon valvuloplasty is a valuable treatment option, especially for high-risk patients who are not candidates for surgical valve replacement. This has spurred healthcare facilities worldwide to adopt these devices, ensuring access to effective therapies. Additionally, increasing awareness about early diagnosis and treatment of valvular conditions is encouraging more patients to seek medical attention, thereby boosting the market for balloon valvuloplasty devices.

How Are Technological Advancements Improving Device Efficiency?

Technological advancements in balloon valvuloplasty devices are significantly enhancing their efficiency and safety. Manufacturers are focusing on developing next-generation devices with features such as high-pressure balloons, advanced steerability, and enhanced compatibility with imaging systems. These improvements enable precise placement and dilation, minimizing the risk of damage to surrounding tissues.

Moreover, the integration of digital tools, such as real-time imaging and navigation systems, is revolutionizing procedural accuracy. These tools allow clinicians to visualize and guide the device during the procedure, ensuring optimal outcomes. Additionally, innovations in materials, such as biocompatible polymers and flexible designs, are improving patient comfort and reducing the likelihood of post-procedure complications. These technological strides are not only enhancing the efficacy of balloon valvuloplasty but also expanding its application across a broader patient population.

What Factors Are Driving the Growth of the Balloon Valvuloplasty Devices Market?

The growth in the balloon valvuloplasty devices market is driven by several factors, including the increasing prevalence of valvular heart diseases, advancements in minimally invasive technologies, and ongoing improvements in device efficiency. The aging global population and the associated rise in cardiovascular conditions have created a pressing need for effective treatment options, making balloon valvuloplasty a critical intervention.

Consumer behavior, particularly the growing demand for minimally invasive procedures with shorter recovery times, is shaping market dynamics. Technological innovations, such as advanced imaging guidance and improved catheter designs, are further supporting market expansion by enhancing procedural outcomes. Additionally, increased investment in healthcare infrastructure and rising awareness about the benefits of early intervention in valvular diseases are driving adoption. These factors collectively underscore the robust growth trajectory of the global balloon valvuloplasty devices market.

SCOPE OF STUDY:

The report analyzes the Balloon Valvuloplasty Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Aortic Valve Stenosis Application, Pulmonary Valve Stenosis Application); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Labs End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • B. Braun Interventional Systems, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • BrosMed Medical Company Limited
  • Edwards Lifesciences Corporation
  • Getinge AB (Getinge Group)
  • Koninklijke Philips NV
  • Medtronic Plc
  • Stryker Corporation
  • Terumo Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Balloon Valvuloplasty Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Valvular Heart Diseases Spurs Demand for Balloon Valvuloplasty Devices
    • Technological Advancements in Minimally Invasive Cardiac Procedures Strengthen Market Growth
    • Increasing Geriatric Population Expands Addressable Market for Balloon Valvuloplasty Solutions
    • Growing Adoption of Catheter-Based Interventions Drives Demand for Advanced Valvuloplasty Devices
    • Expanding Healthcare Infrastructure in Emerging Markets Propels Market Opportunities
    • Rising Awareness About Minimally Invasive Treatment Options Accelerates Adoption Rates
    • Integration of Imaging Technologies with Valvuloplasty Devices Enhances Procedural Accuracy
    • Government Initiatives and Funding for Cardiovascular Health Strengthen Market Demand
    • Increasing Availability of Reimbursement Policies Supports Market Expansion
    • Surge in Demand for Outpatient Procedures Fuels Growth in Ambulatory Surgical Centers
    • High Burden of Congenital Heart Defects Drives Demand for Pediatric Balloon Valvuloplasty Devices
    • Innovations in Balloon Materials and Coatings Improve Device Performance and Durability
    • Expanding Focus on Personalized and Patient-Centric Treatment Approaches Drives Demand
    • Challenges in Open-Heart Surgery Propel Shift Toward Less Invasive Procedures
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Balloon Valvuloplasty Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Balloon Valvuloplasty Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Aortic Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Aortic Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Aortic Valve Stenosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pulmonary Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pulmonary Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pulmonary Valve Stenosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cardiac Catheterization Labs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cardiac Catheterization Labs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Cardiac Catheterization Labs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Balloon Valvuloplasty Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Balloon Valvuloplasty Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Balloon Valvuloplasty Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION